The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically ...

The chief science officer for the U. flagship HIV/AIDS program left his role this week and criticized the Trump ...

By Christy Santhosh and Sriparna Roy April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's ...

U. funding cuts to South Africa have dismantled HIV prevention programmes just as they are needed to support ‌the roll-out of ...

Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso ...

Trump administration officials are putting forward new data that shows U.S. federal anti-HIV/AIDS funding has continued to curb the worldwide epidemic despite accusations from outside public health ...

April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV ...

We found that conscientious objection laws were associated with significant harms to LGBQ+ adults, including a decline in HIV ...

After over a decade with HIV, a Norwegian man received a surprise through a stem cell donation from his sibling. The gifted ...

Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...

More than four decades into the HIV epidemic, progress has transformed treatment and prevention, yet the need remains urgent.

HIV infection remains a global pandemic with more than 40 million people are currently infected. While treatment for HIV has ...